INNOVATE Corp (VATE)
NYSE:VATE
Want to see VATE full AI Analyst Report?
VATE Stock Chart & Stats
$5.05
$0.04(0.71%)
At close: 4:00 PM EST
$5.05
$0.04(0.71%)
Day’s Range― - ―
52-Week Range$3.75 - $16.98
Previous CloseN/A
Volume9.40K
Average Volume (3M)26.90K
Market Cap
$207.77M
Enterprise Value$838.67M
Total Cash (Recent Filing)$134.60M
Total Debt (Recent Filing)$765.50M
Price to Earnings (P/E)―
Beta2.61
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.25
Shares Outstanding13,641,866
10 Day Avg. Volume53,214
30 Day Avg. Volume26,900
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-0.26
Price to Sales (P/S)0.05
P/FCF Ratio0.50
Enterprise Value/Market Cap4.04
Enterprise Value/Revenue0.63
Enterprise Value/Gross Profit4.31
Enterprise Value/Ebitda12.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained strong trailing‑twelve‑month operating and free cash flow provides durable internal funding to service debt, fund capex or strategic initiatives, and smooth working‑capital swings. If maintained, this cash generation can underwrite operations despite accounting losses and high leverage.
Infrastructure BacklogA ~ $1.6B reported backlog and rapid revenue growth at DBMG give multi‑period revenue visibility and support higher EBITDA conversion. As the core earnings engine, backlog steadies cash inflows and bidding pipeline, reducing short‑term revenue volatility in the construction/infrastructure market.
Regulatory Progress (MediBeacon)CE marking and additional clinical/IDE approvals materially increase addressable markets and clinical adoption timelines for MediBeacon products. Regulatory validation reduces commercialization risk, enabling durable revenue opportunities in Europe and supporting long‑term value in the life‑sciences portfolio.
Bears Say
High LeverageVery high debt relative to a minimal equity base sharply reduces financial flexibility and raises refinancing, covenant and insolvency risks. Persistent leverage magnifies earnings volatility and limits ability to absorb shocks, making capital structure a long‑term constraint on strategic options.
Thin ProfitabilityOngoing net losses and near‑zero EBITDA margin indicate limited internal profitability cushion. Thin margins hinder reinvestment, amplify the impact of cost or mix shifts, and increase dependency on cash flow improvements or external capital to sustain growth and service debt over the medium term.
Segment Funding & Corporate Cash StrainCapital needs in R2 and a very small standalone corporate cash balance constrain the holding company’s ability to support smaller but strategically important segments. This structural funding gap could delay commercialization, force asset divestitures, or increase dilutive financing risk over several quarters.
INNOVATE Corp News
VATE FAQ
What was INNOVATE Corp’s price range in the past 12 months?
INNOVATE Corp lowest stock price was $3.75 and its highest was $16.98 in the past 12 months.
What is INNOVATE Corp’s market cap?
INNOVATE Corp’s market cap is $207.77M.
When is INNOVATE Corp’s upcoming earnings report date?
INNOVATE Corp’s upcoming earnings report date is Aug 12, 2026 which is in 71 days.
How were INNOVATE Corp’s earnings last quarter?
INNOVATE Corp released its earnings results on May 14, 2026. The company reported -$1.289 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.289.
Is INNOVATE Corp overvalued?
According to Wall Street analysts INNOVATE Corp’s price is currently Overvalued.
Does INNOVATE Corp pay dividends?
INNOVATE Corp pays a Notavailable dividend of $38.9 which represents an annual dividend yield of N/A. See more information on INNOVATE Corp dividends here
What is INNOVATE Corp’s EPS estimate?
INNOVATE Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does INNOVATE Corp have?
INNOVATE Corp has 13,641,866 shares outstanding.
What happened to INNOVATE Corp’s price movement after its last earnings report?
INNOVATE Corp reported an EPS of -$1.289 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.733%.
Which hedge fund is a major shareholder of INNOVATE Corp?
Currently, no hedge funds are holding shares in VATE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
INNOVATE Corp Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
VATE Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 13.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.61%
12-Months-Change
Fundamentals
Return on Equity
22.84%
Trailing 12-Months
Asset Growth
7.93%
Trailing 12-Months
Company Description
INNOVATE Corp
INNOVATE Corp (VATE) is a forward-thinking technology company specializing in cutting-edge solutions across various sectors including artificial intelligence, renewable energy, and advanced manufacturing. The company focuses on developing innovative products and services that enhance efficiency and sustainability for businesses and consumers alike, leveraging its expertise in software development, hardware integration, and data analytics.
VATE Company Deck
VATE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a predominantly positive operational story driven by a strong Infrastructure / DBMG performance that delivered outsized revenue (up 33% consolidated) and adjusted EBITDA improvement. Significant regulatory and clinical milestones at MediBeacon and international growth at R2 are constructive. However, meaningful challenges remain in smaller but important areas: Life Sciences revenues fell sharply (-48.4%), R2 is seeking external capital, Spectrum experienced advertising weakness and cancellations, DBMG saw ~140 bps gross margin compression, and consolidated debt increased due to PIK interest. Overall, the positive momentum in the company’s largest revenue driver and improved overall profitability outweighs the segment‑level headwinds, but capital structure and segment weaknesses warrant continued attention.View all VATE earnings summariesTechnical Analysis
SUNation Energy
―
Energy Services of America
―
Shimmick Corporation
―
SKK Holdings Limited
―
Ming Shing Group Holdings Limited
―
Ownership Overview
56.57% Insiders
3.14% Mutual Funds
7.95% Other Institutional Investors
30.59% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---